Article Information
History
- January 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Di-Xin Zou†,1,2,3,
- Xue-Dan Meng†,1,2,3,
- Ying Xie1,
- Rui Liu1,
- Jia-Lun Duan1,
- Chun-Jie Bao1,
- Yi-Xuan Liu1,
- Ya-Fei Du1,
- Jia-Rui Xu1,
- Qian Luo1,
- Zhan Zhang1,
- Shuang Ma1,
- Wei-Peng Yang*,3,#,
- Rui-Chao Lin*,2 and
- Wan-Liang Lu*,1
- 1State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, and School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
- 2Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China
- 3Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
- ↵#Correspondence to: luwl{at}bjmu.edu.cn, Dr. Wan-Liang Lu, Ph.D. Professor, School of Pharmaceutical Sciences Peking University, No 38, Xueyuan Rd, Beijing 100191, China Tel & Fax: +8610 82802683
- *Corresponding authors: Dr. Wan-Liang Lu, luwl{at}bjmu.edu.cn, Dr. Rui-Chao Lin, linruichao6666{at}163.com, Dr. Wei-Peng Yang, hrbywp{at}sina.com
↵† Both authors contributed equally to this work.